Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Williams

Showing results (61-70 of 377) with videos related to

Pageof 38
Sort By:
British Journal of Rheumatology|October 1, 1991
Review of UK data on the rheumatic diseases--9. SclerodermaG H Williams, A J Silman
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
The renal response to converting enzyme inhibition and the treatment of sodium-sensitive hypertensionN K Hollenberg, G H Williams
The Journal of Laboratory and Clinical Medicine|May 1, 1972
The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysisR H Underwood, G H Williams
The Journal of Clinical Endocrinology and Metabolism|October 1, 1979
The effect of angiotensin II and saralasin on 18-hydroxy-11-deoxycorticosterone production by isolated human adrenal glomerulosa cellsL M Braley, G H Williams
British Journal of Rheumatology|October 1, 1987
Common-sense beliefs about arthritisG H Williams, P H Wood
Kidney International. Supplement|March 1, 1979
Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertensionN K Hollenberg, G H Williams
Clinical Chemistry|November 1, 1978
Should blood samples for assay of plasma renin activity be chilled?R L Emanuel, G H Williams
Medical Times|November 1, 1980
Adrenal causes of hypertensionR G Dluhy, G H Williams
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1983
Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibitionN K Hollenberg, G H Williams
The American Journal of Medicine|September 27, 1985
Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapyG H Williams, N K Hollenberg
Pageof 38

Showing results (61-70 of 377) with videos related to

Sort By:
Pageof 38
British Journal of Rheumatology|October 1, 1991
Review of UK data on the rheumatic diseases--9. SclerodermaG H Williams, A J Silman
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
The renal response to converting enzyme inhibition and the treatment of sodium-sensitive hypertensionN K Hollenberg, G H Williams
The Journal of Laboratory and Clinical Medicine|May 1, 1972
The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysisR H Underwood, G H Williams
The Journal of Clinical Endocrinology and Metabolism|October 1, 1979
The effect of angiotensin II and saralasin on 18-hydroxy-11-deoxycorticosterone production by isolated human adrenal glomerulosa cellsL M Braley, G H Williams
British Journal of Rheumatology|October 1, 1987
Common-sense beliefs about arthritisG H Williams, P H Wood
Kidney International. Supplement|March 1, 1979
Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertensionN K Hollenberg, G H Williams
Clinical Chemistry|November 1, 1978
Should blood samples for assay of plasma renin activity be chilled?R L Emanuel, G H Williams
Medical Times|November 1, 1980
Adrenal causes of hypertensionR G Dluhy, G H Williams
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1983
Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibitionN K Hollenberg, G H Williams
The American Journal of Medicine|September 27, 1985
Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapyG H Williams, N K Hollenberg
Pageof 38